Literature DB >> 27407894

Fatal Cerebral Leucostasis in Acute Leukaemia with Hyperleucocytosis.

S K Magu1, A K Malviya2.   

Abstract

Entities:  

Keywords:  Hyperleucocytosis; Leucostasis; Leukaemia

Year:  2011        PMID： 27407894      PMCID： PMC4921995          DOI： 10.1016/S0377-1237(06)80073-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  10 in total

Review 1.  Leukocytoreduction for acute leukemia.

Authors:  Pierluigi Porcu; Sherif Farag; Guido Marcucci; Spero R Cataland; Melanie S Kennedy; Michael Bissell
Journal:  Ther Apher       Date:  2002-02

2.  Co-existence of thrombocytopenia and hyperleukocytosis ('critical period') as a risk factor of haemorrhage into the central nervous system in patients with acute leukaemias.

Authors:  Przemysław Nowacki; Barbara Zdziarska; Cezary Fryze; Ignacy Urasiński
Journal:  Haematologia (Budap)       Date:  2002

3.  Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.

Authors:  F J Giles; Y Shen; H M Kantarjian; M J Korbling; S O'Brien; P Anderlini; M Donato; S Pierce; M J Keating; E J Freireich; E Estey
Journal:  Leuk Lymphoma       Date:  2001-06

4.  Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination.

Authors:  A Stucki; A S Rivier; M Gikic; N Monai; M Schapira; O Spertini
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 5.  Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management.

Authors:  P Porcu; L D Cripe; E W Ng; S Bhatia; C M Danielson; A Orazi; L J McCarthy
Journal:  Leuk Lymphoma       Date:  2000-09

6.  Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.

Authors:  A Thiébaut; X Thomas; A Belhabri; B Anglaret; E Archimbaud
Journal:  Ann Hematol       Date:  2000-09       Impact factor: 3.673

7.  Pathophysiology-directed therapy for acute hypoxemic respiratory failure in acute myeloid leukemia with hyperleukocytosis.

Authors:  Jeffrey E Schmidt; Robert F Tamburro; Elaine M Sillos; D Ashley Hill; Raul C Ribeiro; Bassem I Razzouk
Journal:  J Pediatr Hematol Oncol       Date:  2003-07       Impact factor: 1.289

8.  High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.

Authors:  P A Cassileth; L S Sylvester; J M Bennett; C B Begg
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

9.  Spurious platelet counts in acute leukaemia with DIC due to cell fragmentation.

Authors:  J Hammerstrøm
Journal:  Clin Lab Haematol       Date:  1992

Review 10.  Management of unusual presentations of acute leukemia.

Authors:  M R Baer
Journal:  Hematol Oncol Clin North Am       Date:  1993-02       Impact factor: 3.722
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.